Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
NCT Number: NCT02156583
This is an observational study evaluating changes in frailty and associated impairments in older heart failure patients receiving left ventricular assist device therapy.
Looking for future studies?
Notify Me60 year and older
All sexes
Observational
Philadelphia, Pennsylvania, 19107, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline (prior to surgery); 10 days, 1 month, 3 months, and 6 months post-operatively
Frailty will be assess based on the domains initially described by Fried and colleagues: weakness, low physical activity, unintentional weight loss, slowness and exhaustion. Additional frailty measures include the Short Physical Performance Battery (SPPB), as well as gait speed and hand grip strength as single item measures.
Time frame: Baseline (prior to surgery); 10 days and 3 months postoperatively
Time frame: Baseline; 3 and 6 months post-operatively
Thomas Jefferson University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01640769
Cardiac Resynchronization Therapy, Cardiomyopathies
Calgary, Alberta, Canada
View Trial DetailsNCT03446313
Angina Pectoris, Angina, Unstable
Concord, California, United States
View Trial DetailsNCT03036462
Cardiovascular Diseases, Heart Diseases
Hamburg, Free and Hanseatic City of Hamburg, Germany
View Trial DetailsNCT01347567
Acute Decompensated Heart Failure, Cardiovascular Diseases
Herston, Queensland, Australia
View Trial Details